Clinical Trial Update: A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of stereotactic body radiation therapy and radium-223 dichloride for prostate cancer with bone metastases; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Radium-223 dichloride (radium-223 dichloride)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING